A phase Ib/II study of cancer sternness inhibitor napabucasin (BBI-608) in combination with gemcitabine (gem) and nab-paclitaxel (nabPTX) in metastatic pancreatic adenocarcinoma (mPDAC) patients (pts).

被引：14
|
作者：
Bekaii-Saab, Tanios S.
Starodub, Alexander
El-Rayes, Bassel F.
O'Neil, Bert H.
Shanda, Safi
Ciombor, Kristen Keon
Noonan, Anne M.
Hanna, Wahid Tewfik
Sehdev, Amikar
Shaib, Walid Labib
Mikhail, Sameh
Neki, Anterpreet S.
Oh, Cindy
Li, Youzhi
Li, Wei
Borodyansky, Laura
Li, Chiang
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.4106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4106
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer
    Perez, Kimberly
    Weekes, Colin D.
    Cleary, James M.
    Abrams, Thomas Adam
    Blaszkowsky, Lawrence Scott
    Enzinger, Peter C.
    Giannakis, Marios
    Goyal, Lipika
    Meyerhardt, Jeffrey A.
    Rubinson, Douglas Adam
    Yurgelun, Matthew B.
    Stonely, Danielle
    Raghavan, Srivatsan
    Bakir, Basil
    Das, Koushik
    Pitarresi, Jason
    Aguirre, Andrew
    Needle, Michael N.
    Rustgi, Anil
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [22] Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer
    Palacio, Sofia
    Akunyili, Ikechukwu Immanuel
    Ernani, Vinicius
    Macintyre, Jessica
    Merchan, Jaime R.
    Pollack, Terri
    Reis, Isildinha
    Restrepo, Maria H.
    Lima, Caio Max S. Rocha
    Hosein, Peter Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
    Pijnappel, Esther N.
    Wassenaar, Nienke P. M.
    Gurney-Champion, Oliver J.
    Klaassen, Remy
    van der Lee, Koen
    Pleunis-van Empel, Marjolein C. H.
    Richel, Dick J.
    Legdeur, Marie C.
    Nederveen, Aart J.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    CANCERS, 2021, 13 (19)
  • [24] Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
    Pijnappel, E. N.
    Klaassen, R.
    van der Lee, K. S.
    Pleunis-van Empel, M.
    Richel, D.
    Legdeur, M.
    Nederveen, A.
    van Laarhoven, H. W. M.
    Wilmink, H. W.
    ANNALS OF ONCOLOGY, 2019, 30
  • [25] Phase Ib/II study of ALT-803 in combination with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer.
    Acoba, Jared David
    Rock, Amy
    Wong, Hing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [26] A randomized phase II trial comparing different schedules of nab-paclitaxel (nabP) combined with gemcitabine (GEM) as first line treatment for metastatic pancreatic adenocarcinoma (mPDAC).
    Corrie, Philippa
    Qian, Wendi
    Basu, Bristi
    Valle, Juan W.
    Falk, Stephen
    Iwuji, Chinenyu
    Wasan, Harpreet Singh
    Palmer, Daniel H.
    Scott-Brown, Martin
    Wadsley, Jonathan
    Arif, Seema Safia
    Bridgewater, John A.
    Propper, David
    Gillmore, Roopinder
    Gopinathan, Aarthi
    Bax, Lisa
    Machin, Andrea
    Neesse, Albrecht
    Tuveson, David A.
    Jodrell, Duncan Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma (vol 36, pg 96, 2018)
    Weiss, Glen J.
    Blaydorn, Lisa
    Beck, Julia
    Bornemann-Kolatzki, Kirsten
    Urnovitz, Howard
    Schuetz, Ekkhard
    Khemka, Vivek
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 797 - 797
  • [28] Phase I/II trial of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Weiss, Glen J.
    Waypa, Jordan
    Coats, Jessica
    Blaydorn, Lisa
    McGahey, Kayla
    Sangal, Ashish
    Whitehead, Robert P.
    Khemka, Vivek
    CANCER RESEARCH, 2017, 77
  • [29] Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study
    Yu, X.
    Shen, L.
    Hao, J.
    Wang, L.
    Pan, H.
    Han, G.
    Xu, J.
    Zhang, Y.
    Yang, S.
    Ying, J.
    Li, M.
    Begic, D.
    Lu, B.
    Xu, R.
    ANNALS OF ONCOLOGY, 2015, 26 : 66 - 67
  • [30] A Phase II study of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer.
    Zhao, Yannan
    Lv, Fangfang
    Chen, Shen
    Lu, Yunhua
    Cao, Enying
    Wang, Zhonghua
    Zhang, Jian
    Zhang, Sheng
    Cao, Jun
    Zheng, Chunlei
    Wang, Leiping
    Wang, Biyun
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345